These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2693293)

  • 1. Neuropsychological profiles of calcium antagonists.
    Soubrie P
    Fundam Clin Pharmacol; 1989; 3 Suppl():71s-78s. PubMed ID: 2693293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and anticonvulsant effects of Ca2+ channel toxins in DBA/2 mice.
    Jackson HC; Scheideler MA
    Psychopharmacology (Berl); 1996 Jul; 126(1):85-90. PubMed ID: 8853221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats.
    Czyrak A; Mogilnicka E; Maj J
    Neuropharmacology; 1989 Mar; 28(3):229-33. PubMed ID: 2725849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The relationship between anticonvulsant and anti-anxiety effects of calcium channel blockers].
    Kozlovskiĭ VL
    Eksp Klin Farmakol; 1997; 60(5):19-22. PubMed ID: 9483399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium receptor antagonists modify cocaine effects in the central nervous system differently.
    Pani L; Kuzmin A; Diana M; De Montis G; Gessa GL; Rossetti ZL
    Eur J Pharmacol; 1990 Nov; 190(1-2):217-21. PubMed ID: 2076753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianxiety actions of Ca2+ channel antagonists with Vogel-type conflict test in rats.
    Matsumoto Y; Kataoka Y; Watanabe Y; Miyazaki A; Taniyama K
    Eur J Pharmacol; 1994 Oct; 264(1):107-10. PubMed ID: 7828638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychopharmacological properties of calcium channel inhibitors.
    Pucilowski O
    Psychopharmacology (Berl); 1992; 109(1-2):12-29. PubMed ID: 1365644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of calcium antagonists on the nervous system].
    Zhai J; Ma RC
    Sheng Li Ke Xue Jin Zhan; 1989 Oct; 20(4):369-71. PubMed ID: 2561228
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium agonists and antagonists of the dihydropyridine type: antinociceptive effects, interference with opiate-mu-receptor agonists and neuropharmacological actions in rodents.
    Hoffmeister F; Tettenborn D
    Psychopharmacology (Berl); 1986; 90(3):299-307. PubMed ID: 2431429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anxiolytic activity of calcium-channel blockers in tests of anxious behavior in mice and rats].
    Kozlovskiĭ VL
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1999; 49(1):84-95. PubMed ID: 10330709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice.
    Reddy DS; Kulkarni SK
    Brain Res; 1997 Mar; 752(1-2):61-71. PubMed ID: 9106441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Requirement of L-Type Voltage-Dependent Calcium Channel (L-VDCC) in the Rapid-Acting Antidepressant-Like Effects of Scopolamine in Mice.
    Yu H; Li M; Shen X; Lv D; Sun X; Wang J; Gu X; Hu J; Wang C
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):175-186. PubMed ID: 29020410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of diltiazem in convulsive states differ from those previously reported for dihydropyridine calcium channel antagonists.
    Watson WP; Little HJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):321-8. PubMed ID: 7530854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Dec; 11(6):S3-8. PubMed ID: 8169379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The calcium antagonists in the 1990s. An overview.
    Oparil S; Calhoun DA
    Am J Hypertens; 1991 Jul; 4(7 Pt 2):396S-405S. PubMed ID: 1910636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Calcium antagonists": a class of drugs with a bright future. Part II. Determination of basic pharmacological properties.
    Spedding M; Cavero I
    Life Sci; 1984 Aug; 35(6):575-87. PubMed ID: 6087068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between diltiazem and ethanol: differences from those seen with dihydropyridine calcium channel antagonists.
    Watson WP; Little HJ
    Psychopharmacology (Berl); 1994 Mar; 114(2):329-36. PubMed ID: 7838926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of calcium channel blockers on animal behavior in tests to study their anxiolytic activity].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1995; 58(1):18-20. PubMed ID: 7787686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP sensitive potassium channels: potential drug targets in neuropsychopharmacology.
    Gehlert DR; Robertson DW
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1093-102. PubMed ID: 7846282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-channel antagonists inhibit marble-burying behavior in mice.
    Egashira N; Okuno R; Abe M; Matsushita M; Mishima K; Iwasaki K; Oishi R; Nishimura R; Matsumoto Y; Fujiwara M
    J Pharmacol Sci; 2008 Sep; 108(1):140-3. PubMed ID: 18758134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.